Conferenza

European Statistical Forum - SPONSORS

Design and Analysis of Trials in Rare Diseases and Gene Therapies

12 and 13 November 2026

Budapest

Attestato di partecipazione Attestato di partecipazione

English

The conference is sponsored by

Would you like to become a Sponsor?
Please contact us to receive more information about the sponsorship offers and which benefits they include.

 Indietro
Registrati
Early bird
Acquistabile fino al 15/10/2026
€645,00
Ordinaria
Acquistabile fino al 11/11/2026
€765,00
Freelance - Privato - Accademia - Pubblica Amministrazione
Acquistabile fino al 11/11/2026
€460,00
Networking Dinner
Acquistabile fino al 06/11/2026
€65,00
Svuota
Versione Stampabile
Contattaci per ricevere maggiori informazioni sulle opportunità di sponsorizzazione
Diventa Sponsor
Sponsors
Arithmos
Media Partner
Gene Therapy Net
Patrocinio
Portuguese Statistical Society (SPE)
Code of Good Conduct - 270kB
<p style="text-align: center;"><strong>NH Budapest City</strong><br /> <span>Vígszínház u.3 – 1137 Budapest</span></p>

NH Budapest City
Vígszínház u.3 – 1137 Budapest

<p style="text-align: center;"><strong>NH Budapest City</strong><br /> <span>Vígszínház u.3 – 1137 Budapest</span></p>
<p style="text-align: center;"><strong>NH Budapest City</strong><br /> <span>Vígszínház u.3 – 1137 Budapest</span></p>
<p style="text-align: center;"><strong>NH Budapest City</strong><br /> <span>Vígszínház u.3 – 1137 Budapest</span></p>
Vedi tutte le edizioni
European Statistical Forum

FAQ – Frequently Asked Questions

Is European Statistical Forum held annually?

Yes. European Statistical Forum is an annual biostatistics conference held each autumn in European locations. Each edition focuses on current developments in clinical trial design, statistical methodology, and regulatory expectations relevant to biostatisticians and clinical development professionals.

What is the difference between individual edition pages and this main page?

This page provides an overview of European Statistical Forum as an annual biostatistics conference series, covering its history, recurring themes, and professional community. Individual edition pages offer specific details about that year’s programme, speakers, registration, and focused topics. This main page serves as the canonical reference for the overall European Statistical Forum conference series.

Who should attend European Statistical Forum?

The biostatistics conference is designed for biostatisticians, pharmacometricians, clinical development scientists, data scientists, regulatory affairs specialists, and anyone responsible for clinical trial design, statistical analysis, or regulatory evaluation of clinical research in pharmaceutical companies, CROs, academic institutions, or regulatory agencies.

Does European Statistical Forum cover both frequentist and Bayesian approaches?

Yes. European Statistical Forum provides comprehensive coverage of both frequentist and Bayesian statistical frameworks. Sessions demonstrate when each approach is most appropriate, how to implement both methods in practice, and strategies for regulatory acceptance. The conference recognizes that modern clinical trial design often requires flexible use of multiple statistical paradigms depending on development context.

Is European Statistical Forum relevant for early-career biostatisticians?

Yes. While statistical content is rigorous, European Statistical Forum is designed to accommodate varying expertise levels. Sessions provide foundational context before advanced topics, and the conference offers excellent learning opportunities for early-career biostatisticians to understand real-world application of statistical methods in drug development. Networking with senior statisticians provides invaluable professional development.

How does European Statistical Forum address gene therapy trials specifically?

European Statistical Forum dedicates substantial attention to statistical challenges unique to gene therapy clinical trials, including small sample sizes, one-time interventions requiring long-term follow-up, ethical constraints on randomization, and limited natural history data. Sessions provide practical guidance on designing robust gene therapy trials using Bayesian methods, adaptive designs, external controls, and other innovative approaches that meet regulatory expectations despite inherent study design constraints.

How can I stay informed about upcoming European Statistical Forum editions?

Subscribe to the LS Academy newsletter or follow our updates to receive announcements about European Statistical Forum editions, including programme details, speaker confirmations, and early registration opportunities for this leading biostatistics conference.

Stay Connected with European Statistical Forum

Join the European biostatistics community. Stay informed about upcoming editions, programme announcements, and developments in clinical trial design and statistical methodology.